US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 16.040
  • +0.440+2.82%
Trading Nov 22 14:56 ET
1.37BMarket Cap-4406P/E (TTM)

Syndax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
12.5M
3.5M
0
0
0
0
0
0
0
0
Operating revenue
--12.5M
--3.5M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
81.13%102.08M
56.44%77.72M
72.80%79.51M
51.53%229.95M
85.34%77.91M
60.37%56.36M
31.69%49.68M
24.84%46.02M
33.72%151.76M
36.35%42.03M
Selling and administrative expenses
80.14%31.11M
94.86%29.06M
92.48%23.02M
101.22%66.92M
123.50%22.78M
109.56%17.27M
86.66%14.91M
74.97%11.96M
31.76%33.26M
47.13%10.19M
-General and administrative expense
80.14%31.11M
94.86%29.06M
92.48%23.02M
----
----
109.56%17.27M
86.66%14.91M
74.97%11.96M
----
----
Research and development costs
81.57%70.97M
39.96%48.66M
65.89%56.49M
37.58%163.03M
73.13%55.13M
45.30%39.09M
16.92%34.76M
13.43%34.05M
34.28%118.5M
33.23%31.84M
Operating profit
-58.95%-89.58M
-49.39%-74.22M
-72.80%-79.51M
-51.53%-229.95M
-85.34%-77.91M
-60.37%-56.36M
-31.69%-49.68M
-24.84%-46.02M
-678.78%-151.76M
-143.90%-42.03M
Net non-operating interest income expense
2.73%5.42M
21.00%6.24M
42.99%7.2M
666.18%20.96M
86.32%5.49M
15,884.85%5.28M
2,717.49%5.16M
1,279.39%5.04M
282.82%2.74M
2,905.10%2.95M
Non-operating interest income
1.81%5.44M
21.06%6.28M
42.95%7.26M
260.41%21.16M
85.74%5.55M
200.11%5.35M
491.23%5.19M
2,166.07%5.08M
1,357.07%5.87M
3,183.52%2.99M
Non-operating interest expense
-67.14%23K
28.57%45K
37.50%55K
-93.37%208K
46.51%63K
-96.00%70K
-94.96%35K
-93.86%40K
65.19%3.14M
714.29%43K
Other net income (expense)
148.48%32K
7.53%-86K
40.82%-87K
-14.24%-361K
48.11%-55K
77.63%-66K
-200.00%-93K
-226.72%-147K
-256.44%-316K
-130.20%-106K
Other non- operating income (expenses)
148.48%32K
7.53%-86K
40.82%-87K
-14.24%-361K
48.11%-55K
77.63%-66K
-200.00%-93K
-226.72%-147K
-256.44%-316K
-130.20%-106K
Income before tax
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
Income tax
Net income
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
Net income continuous Operations
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
Minority interest income
Net income attributable to the parent company
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
Basic earnings per share
-34.25%-0.98
-25.00%-0.8
-44.07%-0.85
-21.14%-2.98
-61.29%-1
-25.86%-0.73
-3.23%-0.64
6.35%-0.59
-612.50%-2.46
-134.25%-0.62
Diluted earnings per share
-34.25%-0.98
-25.00%-0.8
-44.07%-0.85
-21.14%-2.98
-61.29%-1
-25.86%-0.73
-3.23%-0.64
6.35%-0.59
-634.78%-2.46
-134.25%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 12.5M3.5M00000000
Operating revenue --12.5M--3.5M--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 81.13%102.08M56.44%77.72M72.80%79.51M51.53%229.95M85.34%77.91M60.37%56.36M31.69%49.68M24.84%46.02M33.72%151.76M36.35%42.03M
Selling and administrative expenses 80.14%31.11M94.86%29.06M92.48%23.02M101.22%66.92M123.50%22.78M109.56%17.27M86.66%14.91M74.97%11.96M31.76%33.26M47.13%10.19M
-General and administrative expense 80.14%31.11M94.86%29.06M92.48%23.02M--------109.56%17.27M86.66%14.91M74.97%11.96M--------
Research and development costs 81.57%70.97M39.96%48.66M65.89%56.49M37.58%163.03M73.13%55.13M45.30%39.09M16.92%34.76M13.43%34.05M34.28%118.5M33.23%31.84M
Operating profit -58.95%-89.58M-49.39%-74.22M-72.80%-79.51M-51.53%-229.95M-85.34%-77.91M-60.37%-56.36M-31.69%-49.68M-24.84%-46.02M-678.78%-151.76M-143.90%-42.03M
Net non-operating interest income expense 2.73%5.42M21.00%6.24M42.99%7.2M666.18%20.96M86.32%5.49M15,884.85%5.28M2,717.49%5.16M1,279.39%5.04M282.82%2.74M2,905.10%2.95M
Non-operating interest income 1.81%5.44M21.06%6.28M42.95%7.26M260.41%21.16M85.74%5.55M200.11%5.35M491.23%5.19M2,166.07%5.08M1,357.07%5.87M3,183.52%2.99M
Non-operating interest expense -67.14%23K28.57%45K37.50%55K-93.37%208K46.51%63K-96.00%70K-94.96%35K-93.86%40K65.19%3.14M714.29%43K
Other net income (expense) 148.48%32K7.53%-86K40.82%-87K-14.24%-361K48.11%-55K77.63%-66K-200.00%-93K-226.72%-147K-256.44%-316K-130.20%-106K
Other non- operating income (expenses) 148.48%32K7.53%-86K40.82%-87K-14.24%-361K48.11%-55K77.63%-66K-200.00%-93K-226.72%-147K-256.44%-316K-130.20%-106K
Income before tax -64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M
Income tax
Net income -64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M
Net income continuous Operations -64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M
Minority interest income
Net income attributable to the parent company -64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M
Basic earnings per share -34.25%-0.98-25.00%-0.8-44.07%-0.85-21.14%-2.98-61.29%-1-25.86%-0.73-3.23%-0.646.35%-0.59-612.50%-2.46-134.25%-0.62
Diluted earnings per share -34.25%-0.98-25.00%-0.8-44.07%-0.85-21.14%-2.98-61.29%-1-25.86%-0.73-3.23%-0.646.35%-0.59-634.78%-2.46-134.25%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data